VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q64682880 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010733.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q64682880‏
024 ‎‡a 0000-0002-4585-6959‏ ‎‡2 orcid‏
024 ‎‡a 6701492792‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q64682880‏
100 0 ‎‡a Carmen Alvarez-Dominguez‏ ‎‡9 fr‏ ‎‡9 ast‏ ‎‡9 de‏ ‎‡9 it‏ ‎‡9 es‏
400 0 ‎‡a Carmen Alvarez-Dominguez‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Carmen Alvarez-Dominguez‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A Comparison Between Recombinant <i>Listeria</i> GAPDH Proteins and GAPDH Encoding mRNA Conjugated to Lipids as Cross-Reactive Vaccines for <i>Listeria, Mycobacterium</i>, and <i>Streptococcus</i>‏
670 ‎‡a Author's A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection‏
670 ‎‡a Author's A novel therapy for melanoma developed in mice: transformation of melanoma into dendritic cells with Listeria monocytogenes.‏
670 ‎‡a Author's Biomarker Tools to Design Clinical Vaccines Determined from a Study of Annual Listeriosis Incidence in Northern Spain.‏
670 ‎‡a Author's Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH.‏
670 ‎‡a Author's Characterization of a Listeria monocytogenes protein interfering with Rab5a.‏
670 ‎‡a Author's Dendritic cell therapy in melanoma.‏
670 ‎‡a Author's Dissociation of innate immune responses in microglia infected with Listeria monocytogenes.‏
670 ‎‡a Author's Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma.‏
670 ‎‡a Author's GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination.‏
670 ‎‡a Author's Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.‏
670 ‎‡a Author's Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines.‏
670 ‎‡a Author's Increased expression of Rab5a correlates directly with accelerated maturation of Listeria monocytogenes phagosomes.‏
670 ‎‡a Author's Inhibition of Rab5a exchange activity is a key step for Listeria monocytogenes survival.‏
670 ‎‡a Author's Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell‏
670 ‎‡a Author's Iron salts and iron-containing porphyrins block presentation of protein antigens by macrophages to MHC class II-restricted T cells‏
670 ‎‡a Author's LIMP-2 links late phagosomal trafficking with the onset of the innate immune response to Listeria monocytogenes: a role in macrophage activation‏
670 ‎‡a Author's Membrane trafficking along the phagocytic pathway‏
670 ‎‡a Author's Novel nanoparticle vaccines for Listeriosis‏
670 ‎‡a Author's Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells‏
670 ‎‡a Author's Phagocytosed live Listeria monocytogenes influences Rab5-regulated in vitro phagosome-endosome fusion.‏
670 ‎‡a Author's Phagosomes induced by cytokines function as anti-Listeria vaccines: novel role for functional compartmentalization of STAT-1 protein and cathepsin-D‏
670 ‎‡a Author's Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities.‏
670 ‎‡a Author's The consequences of the intracellular retention of pathogen-derived T-cell-independent antigens on protein presentation to T cells.‏
670 ‎‡a Author's The contribution of both oxygen and nitrogen intermediates to the intracellular killing mechanisms of C1q-opsonized Listeria monocytogenes by the macrophage-like IC-21 cell line.‏
670 ‎‡a Author's The innate immunity role of cathepsin-D is linked to Trp-491 and Trp-492 residues of listeriolysin O.‏
909 ‎‡a (orcid) 0000000245856959‏ ‎‡9 1‏
909 ‎‡a (scopus) 6701492792‏ ‎‡9 1‏
919 ‎‡a characterizationofalisteriamonocytogenesproteininterferingwithrab5a‏ ‎‡A Characterization of a Listeria monocytogenes protein interfering with Rab5a.‏ ‎‡9 1‏
919 ‎‡a comparisonbetweenrecombinant1listeria1gapdhproteinsandgapdhencodingmrnaconjugatedtolipidsascrossreactivevaccinesfor1listeriamycobacterium1and1streptococcus1‏ ‎‡A A Comparison Between Recombinant <i>Listeria</i> GAPDH Proteins and GAPDH Encoding mRNA Conjugated to Lipids as Cross-Reactive Vaccines for <i>Listeria, Mycobacterium</i>, and <i>Streptococcus</i>‏ ‎‡9 1‏
919 ‎‡a goldglyconanoparticlecarryingalisteriolysinopeptideandformulatedwithadvaxtmdeltainulinadjuvantinducesrobusttcellprotectionagainstlisteriainfection‏ ‎‡A A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection‏ ‎‡9 1‏
919 ‎‡a noveltherapyformelanomadevelopedinmicetransformationofmelanomaintodendriticcellswithlisteriamonocytogenes‏ ‎‡A A novel therapy for melanoma developed in mice: transformation of melanoma into dendritic cells with Listeria monocytogenes.‏ ‎‡9 1‏
919 ‎‡a cellularvaccinesinlisteriosisroleofthelisteriaantigengapdh‏ ‎‡A Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH.‏ ‎‡9 1‏
919 ‎‡a biomarkertoolstodesignclinicalvaccinesdeterminedfromastudyofannuallisteriosisincidenceinnorthernspain‏ ‎‡A Biomarker Tools to Design Clinical Vaccines Determined from a Study of Annual Listeriosis Incidence in Northern Spain.‏ ‎‡9 1‏
919 ‎‡a innateimmunityroleofcathepsin500islinkedtotrp491andtrp492residuesoflisteriolysino‏ ‎‡A The innate immunity role of cathepsin-D is linked to Trp-491 and Trp-492 residues of listeriolysin O.‏ ‎‡9 1‏
919 ‎‡a contributionofbothoxygenandnitrogenintermediatestotheintracellularkillingmechanismsofc1qopsonizedlisteriamonocytogenesbythemacrophagelikeic21cellline‏ ‎‡A The contribution of both oxygen and nitrogen intermediates to the intracellular killing mechanisms of C1q-opsonized Listeria monocytogenes by the macrophage-like IC-21 cell line.‏ ‎‡9 1‏
919 ‎‡a consequencesoftheintracellularretentionofpathogenderivedtcellindependentantigensonproteinpresentationtotcells‏ ‎‡A The consequences of the intracellular retention of pathogen-derived T-cell-independent antigens on protein presentation to T cells.‏ ‎‡9 1‏
919 ‎‡a pregnancyvaccinationwithgoldglyconanoparticlescarryinglisteriamonocytogenespeptidesprotectsagainstlisteriosisandbrainandcutaneousassociatedmorbidities‏ ‎‡A Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities.‏ ‎‡9 1‏
919 ‎‡a phagosomesinducedbycytokinesfunctionasantilisteriavaccinesnovelroleforfunctionalcompartmentalizationofstat1proteinandcathepsin500‏ ‎‡A Phagosomes induced by cytokines function as anti-Listeria vaccines: novel role for functional compartmentalization of STAT-1 protein and cathepsin-D‏ ‎‡9 1‏
919 ‎‡a phagocytosedlivelisteriamonocytogenesinfluencesrab5regulatedinvitrophagosomeendosomefusion‏ ‎‡A Phagocytosed live Listeria monocytogenes influences Rab5-regulated in vitro phagosome-endosome fusion.‏ ‎‡9 1‏
919 ‎‡a oxidationofdefinedantigensallowsproteinunfoldingandincreasesbothproteolyticprocessingandexposespeptideepitopeswhicharerecognizedbyspecifictcells‏ ‎‡A Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells‏ ‎‡9 1‏
919 ‎‡a novelnanoparticlevaccinesforlisteriosis‏ ‎‡A Novel nanoparticle vaccines for Listeriosis‏ ‎‡9 1‏
919 ‎‡a membranetraffickingalongthephagocyticpathway‏ ‎‡A Membrane trafficking along the phagocytic pathway‏ ‎‡9 1‏
919 ‎‡a limp2linkslatephagosomaltraffickingwiththeonsetoftheinnateimmuneresponsetolisteriamonocytogenesaroleinmacrophageactivation‏ ‎‡A LIMP-2 links late phagosomal trafficking with the onset of the innate immune response to Listeria monocytogenes: a role in macrophage activation‏ ‎‡9 1‏
919 ‎‡a ironsaltsandironcontainingporphyrinsblockpresentationofproteinantigensbymacrophagestomhcclass2restrictedtcells‏ ‎‡A Iron salts and iron-containing porphyrins block presentation of protein antigens by macrophages to MHC class II-restricted T cells‏ ‎‡9 1‏
919 ‎‡a inhibitoryeffectsofthymusindependenttype2antigensonmhcclass2restrictedantigenpresentationcomparativeanalysisofcarbohydratestructuresandtheantigenpresentingcell‏ ‎‡A Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell‏ ‎‡9 1‏
919 ‎‡a inhibitionofrab5aexchangeactivityisakeystepforlisteriamonocytogenessurvival‏ ‎‡A Inhibition of Rab5a exchange activity is a key step for Listeria monocytogenes survival.‏ ‎‡9 1‏
919 ‎‡a increasedexpressionofrab5acorrelatesdirectlywithacceleratedmaturationoflisteriamonocytogenesphagosomes‏ ‎‡A Increased expression of Rab5a correlates directly with accelerated maturation of Listeria monocytogenes phagosomes.‏ ‎‡9 1‏
919 ‎‡a identificationandcharacterisationoftcellepitopesforincorporationintodendriticcelldeliveredlisteriavaccines‏ ‎‡A Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines.‏ ‎‡9 1‏
919 ‎‡a goldglyconanoparticlescoupledtolisteriolysino9199peptideserveasadjuvanttherapyagainstmelanoma‏ ‎‡A Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.‏ ‎‡9 1‏
919 ‎‡a gnpgapdh122nanovaccinespreventneonatallisteriosisbyblockingmicroglialapoptosisandbacterialdissemination‏ ‎‡A GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination.‏ ‎‡9 1‏
919 ‎‡a exceptionalantineoplasticactivityofadendriticcelltargetedvaccineloadedwithalisteriapeptideproposedagainstmetastaticmelanoma‏ ‎‡A Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma.‏ ‎‡9 1‏
919 ‎‡a dissociationofinnateimmuneresponsesinmicrogliainfectedwithlisteriamonocytogenes‏ ‎‡A Dissociation of innate immune responses in microglia infected with Listeria monocytogenes.‏ ‎‡9 1‏
919 ‎‡a dendriticcelltherapyinmelanoma‏ ‎‡A Dendritic cell therapy in melanoma.‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000116824301‏
996 ‎‡2 BNE|XX1429961‏
996 ‎‡2 BNCHL|10000000000000000827009‏
996 ‎‡2 BNCHL|10000000000000000242772‏
996 ‎‡2 ISNI|0000000060915879‏
996 ‎‡2 LC|n 88159126‏
996 ‎‡2 LC|n 83164256‏
996 ‎‡2 ISNI|0000000044256244‏
996 ‎‡2 LC|no2024081419‏
996 ‎‡2 ISNI|0000000079894350‏
996 ‎‡2 ISNI|0000000388209468‏
996 ‎‡2 BIBSYS|15029127‏
996 ‎‡2 SELIBR|399506‏
996 ‎‡2 BNCHL|10000000000000000061551‏
996 ‎‡2 SUDOC|221442162‏
996 ‎‡2 NUKAT|n 2009111908‏
996 ‎‡2 LC|n 2005018737‏
996 ‎‡2 NTA|296696668‏
996 ‎‡2 RERO|A008874054‏
996 ‎‡2 LC|ns2012002685‏
996 ‎‡2 DNB|1057542067‏
996 ‎‡2 RERO|A016763809‏
996 ‎‡2 ISNI|000000008001164X‏
996 ‎‡2 J9U|987007421624705171‏
996 ‎‡2 BNE|XX1294862‏
996 ‎‡2 LC|no 00048775‏
996 ‎‡2 BNE|XX1586564‏
996 ‎‡2 DNB|1056741910‏
996 ‎‡2 DNB|1056279516‏
996 ‎‡2 LC|no2014103950‏
996 ‎‡2 DNB|1056536780‏
996 ‎‡2 BNCHL|10000000000000000187205‏
996 ‎‡2 DNB|137616503‏
996 ‎‡2 DNB|1057301922‏
996 ‎‡2 LC|n 94098366‏
996 ‎‡2 LC|n 95043768‏
996 ‎‡2 NYNYRILM|83517‏
996 ‎‡2 BNCHL|10000000000000000210386‏
996 ‎‡2 BIBSYS|3111934‏
996 ‎‡2 SUDOC|175373507‏
996 ‎‡2 ISNI|0000000039958794‏
996 ‎‡2 LC|nr 97032041‏
996 ‎‡2 BIBSYS|90698285‏
996 ‎‡2 BNC|981058518414606706‏
996 ‎‡2 SUDOC|182656160‏
996 ‎‡2 BNE|XX906239‏
996 ‎‡2 BNE|XX958035‏
996 ‎‡2 LC|n 00111740‏
996 ‎‡2 RERO|A014051513‏
996 ‎‡2 BNE|XX1168930‏
996 ‎‡2 BNE|XX5429902‏
996 ‎‡2 SUDOC|145488713‏
996 ‎‡2 BNF|13823510‏
996 ‎‡2 BNE|XX888305‏
996 ‎‡2 ISNI|0000000377089536‏
996 ‎‡2 NTA|073146390‏
996 ‎‡2 BNE|XX1116588‏
996 ‎‡2 NUKAT|n 2011056254‏
996 ‎‡2 ISNI|0000000031234206‏
996 ‎‡2 LC|nb 97031608‏
996 ‎‡2 J9U|987007258594805171‏
996 ‎‡2 ISNI|0000000072451637‏
996 ‎‡2 BNF|14646053‏
996 ‎‡2 NTA|344536122‏
996 ‎‡2 SUDOC|059818778‏
996 ‎‡2 BNC|981060894566906706‏
996 ‎‡2 LC|no2003049234‏
996 ‎‡2 BNE|XX5011230‏
996 ‎‡2 LC|n 98112268‏
996 ‎‡2 BNF|14403740‏
996 ‎‡2 BNC|981058526349906706‏
996 ‎‡2 ISNI|0000000116523103‏
996 ‎‡2 BNE|XX4936883‏
996 ‎‡2 DNB|1057210277‏
996 ‎‡2 SUDOC|153814837‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏